Eye injection heart risk probe: 180 patients enrolled
NCT ID NCT07550777
First seen Apr 29, 2026 · Last updated Apr 29, 2026
Summary
This study looks at whether repeated eye injections of bevacizumab, a common treatment for diabetic eye disease and macular degeneration, might affect heart health. Researchers will measure certain blood enzymes linked to heart disease in 180 adults who have had at least two injections. The goal is to better understand the safety of this long-term treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ataturk University Research Hospital, Department of Ophthalmology
RECRUITINGErzurum, Erzurum, 25240, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.